FGFR4 and hepatocellular carcinoma: Furthermore, up-regulation of fibroblast growth factor receptor 4 (FGFR4) levels, a target for new small molecule inhibitors for the treatment of hepatocellular carcinoma [33], may also compensate the inhibition of proliferation.